7-(Trifluoromethyl)quinazoline-2,4(1H,3H)-dione, 95.0%, 250mg

8-METHYL-1,4-DIOXASPIRO[4.5]DECANE-8-CARBOXYLIC ACID, 95.0%, 1g

(2E)-3-[6-(Trifluoromethyl)pyridin-3-yl]propenoic acid, 95.0%, 5g

1-tert-Butyl 2-ethyl 5-hydroxypiperidine-1,2-dicarboxylate, 95%, 25g

Hexanoyl Chloride>98.0%(GC)(T)100g

(4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R,16S)-5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid, 99.5%, 5g

N-Methoxy-N-methyltrifluoroacetamide, 97.0%, 5g

N-(11-BROMOUNDECYL)CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 5g

5-Bromo-4-chloro-1H-indole, 97.0%, 5g

2,3-Difluoro-4-(trifluoromethyl)pyridine, 97%, 1g

1-TERT-BUTYL 3-ETHYL 5,5-DIMETHYL-4-OXOPIPERIDINE-1,3-DICARBOXYLATE, 95.0%, 1g

N-(2-(2-Methoxy-4-(methylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)formamide, 97%, 1g

Thalidomide-NH-C6-NH2 (TFA), 250mg